Default: Movement Disorders

ISSN: 0885-3185

Journal Home

Journal Guideline

Movement Disorders Q1 Unclaimed

John Wiley and Sons Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Movement Disorders is a journal indexed in SJR in Neurology (clinical) and Neurology with an H index of 198. It has a price of 2500 €. It has an SJR impact factor of 3,352 and it has a best quartile of Q1. It is published in English.

Movement Disorders focuses its scope in these topics and keywords: parkinsons, disease, patients, early, study, trial, stimulation, clinical, parkinsonian, twophased, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

2500 €

Gold OA

-

Green OA

0 €

Non OA

Metrics

Movement Disorders

3,352

SJR Impact factor

198

H Index

418

Total Docs (Last Year)

981

Total Docs (3 years)

13455

Total Refs

5387

Total Cites (3 years)

609

Citable Docs (3 years)

5,35

Cites/Doc (2 years)

32,19

Ref/Doc

Aims and Scope


parkinsons, disease, patients, early, study, trial, stimulation, clinical, parkinsonian, twophased, tourette, brain, agent, movement, lowdose, reuptake, rasagiline, combination, common, dyskinesia, alphasynuclein, monoamine, motor, pb, pramipexole, prevalence, randomized,


Best articles

"Mistaken diagnosis of psychogenic gait disorder in a man with status cataplecticus (""Limp Man Syndrome"")"

View more

A ?cure? for Parkinson's disease: Can neuroprotection be proven with current trial designs?

View more

Accuracy of clinical diagnosis of progressive supranuclear palsy

View more

Adverse effects of dopamine potentiation by long-term treatment with selegiline

View more

Alteration in a-synuclein mRNA expression in Parkinson's disease

View more

Anomalies of asymmetry of clinical signs in parkinsonism

View more

Anxiety in musicians with focal dystonia and those with chronic pain

View more

Assessing comorbidity in patients with Parkinson's disease

View more

Assessing quality of life in Parkinson's disease: Can a short-form questionnaire be useful?

View more

Asymmetrical awake bruxism associated with multiple system atrophy

View more

Autosomal recessive juvenile parkinsonismCys212Tyr mutation in parkin renders lymphocytes susceptible to dopamine- and iron-mediated apoptosis

View more

Basic and therapeutic aspects of neurotonins

View more
SHOW MORE ARTICLES

Botulinum toxin in neuro-urological disorders

View more

Botulinum toxin treatment of secretory disorders

View more

Cabergoline versus levodopa monotherapy

View more

Cardiovascular effects of methamphetamine in Parkinson's disease patients

View more

Cerebrospinal fluid Abeta42levels in multiple system atrophy

View more

Cerebrospinal fluid analysis for Whipple's disease in patients with progressive supranuclear palsy

View more

Chorea and contraceptives: Case report with pet study and review of the literature

View more

Chorea-acanthocytosis associated with tourettism

View more

Clinical and genetic features of myoclonus-dystonia in 3 cases: A video presentation

View more

Clinical characteristics of Parkinson's disease among Inuit in Greenland and inhabitants of the Faroe Islands and Als (Denmark)

View more

Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration

View more

Clinical signs and symptoms in a large hereditary spastic paraparesis pedigree with a novel spastin mutation

View more

Comments

No comments ... Be the first to comment!